Cargando…
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine
Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality of both young adults of less than 45 years of age and the elderly, and contributes to about 30% of all injury deaths in the United States of America. Whereas there has been a significant improvement in our under...
Autores principales: | Hoffer, Barry J., Pick, Chaim G., Hoffer, Michael E., Becker, Robert E., Chiang, Yung-Hsiao, Greig, Nigel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591517/ https://www.ncbi.nlm.nih.gov/pubmed/28886718 http://dx.doi.org/10.1186/s12929-017-0377-1 |
Ejemplares similares
-
(−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury
por: Greig, Nigel H., et al.
Publicado: (2019) -
(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and
Behavioral Impairments Induced by Traumatic Brain Injury in Mice
por: Hsueh, Shih-Chang, et al.
Publicado: (2019) -
Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
por: Eakin, Katharine, et al.
Publicado: (2014) -
Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms
por: Tweedie, David, et al.
Publicado: (2016) -
Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study
por: Hoffer, Michael E., et al.
Publicado: (2013)